Abstract
IntroductionHere we report the glycemic efficacy and safety of ertugliflozin in patients in the VERTIS CV cardiovascular outcome trial with chronic kidney disease (CKD) stage 3.Research design and methodsPrespecified and...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have